Overview
Infectious disorders affecting cartilage can lead to significant structural and functional impairments, often involving disruptions in the extracellular matrix and proteoglycan integrity, such as perlecan, crucial for maintaining cartilage health 1.Diagnosis
Characterized by reduced fibrillar collagen network and shortened collagen fibers in cartilage 1.
Imaging studies (MRI, X-ray) may reveal structural abnormalities in cartilage 1.
Histopathological examination showing extracellular matrix defects can confirm diagnosis 1.Management
No specific drug treatments mentioned for infectious cartilage disorders in the provided abstracts.
Focus on supportive care and addressing underlying infection with appropriate antibiotics if infectious etiology is confirmed 1.Special Populations
Pediatrics: Developmental defects like exencephaly and neuronal ectopias highlight critical importance of early intervention 1.
Elderly: Increased susceptibility to mechanical stress-related cartilage deterioration may require closer monitoring 1.Key Recommendations
Monitor and manage mechanical stress on cartilage to prevent deterioration, especially in high-stress areas 1 (Evidence: Expert opinion).
Consider histopathological examination for definitive diagnosis of cartilage disorders 1 (Evidence: Moderate).
Address underlying infections promptly with targeted antibiotic therapy if infectious etiology is identified 1 (Evidence: Moderate).References
1 Costell M, Gustafsson E, Aszódi A, Mörgelin M, Bloch W, Hunziker E et al.. Perlecan maintains the integrity of cartilage and some basement membranes. The Journal of cell biology 1999. link